These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12586130)

  • 1. Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.
    Andersen K; Hurlen M; Arnesen H; Seljeflot I
    Thromb Res; 2002 Oct; 108(1):37-42. PubMed ID: 12586130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new definition of aspirin non-responsiveness by platelet function analyzer-100 and its predictors.
    Abaci A; Caliskan M; Bayram F; Yilmaz Y; Cetin M; Unal A; Cetin S
    Platelets; 2006 Feb; 17(1):7-13. PubMed ID: 16308181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
    Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for aspirin resistance in stable coronary artery patients by three different tests.
    Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I
    Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment.
    Brodin E; Seljeflot I; Arnesen H; Hurlen M; Appelbom H; Hansen JB
    Thromb Res; 2009 Feb; 123(4):573-9. PubMed ID: 18474393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
    Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Lip GY
    Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction.
    Hurlen M; Seljeflot I; Arnesen H
    Scand Cardiovasc J; 1998; 32(4):233-7. PubMed ID: 9802142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients.
    Lepäntalo A; Mikkelsson J; Reséndiz JC; Viiri L; Backman JT; Kankuri E; Karhunen PJ; Lassila R
    Thromb Haemost; 2006 Feb; 95(2):253-9. PubMed ID: 16493486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin.
    Takahashi S; Ushida M; Komine R; Shimizu A; Uchida T; Ishihara H; Shibano T; Watanabe G; Ikeda Y; Murata M
    Thromb Res; 2007; 119(4):517-24. PubMed ID: 16793119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial disease.
    Mueller T; Haltmayer M; Poelz W; Haidinger D
    Vasc Endovascular Surg; 2003; 37(2):117-23. PubMed ID: 12669143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
    Kojuri J; Mahmoody Y; Zangbar Sabegh B; Jannati M; Mahboodi A; Khalili A
    Cardiovasc Ther; 2010 Jun; 28(3):147-52. PubMed ID: 20557313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.
    Anand SS; Yusuf S; Pogue J; Weitz JI; Flather M
    Circulation; 1998 Sep; 98(11):1064-70. PubMed ID: 9736592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to aspirin in patients after coronary artery bypass grafting is transient: impact on the monitoring of aspirin antiplatelet therapy.
    Golański J; Chłopicki S; Golański R; Gresner P; Iwaszkiewicz A; Watala C
    Ther Drug Monit; 2005 Aug; 27(4):484-90. PubMed ID: 16044106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.